Skip to main content
GUIDE 00 / TIRZEPATIDE

Drug researchers made tirzepatide to act like GIP and GLP-1, two gut hormones. Nine large phase-3 studies then tracked obesity, sleep apnea, and type 2 diabetes.

Here’s what happened to people, what remains unsure, and what you can ask at your next visit.

Blueprint-style schematic of an abstract 39-node peptide chain with two highlighted binding sites

What tirzepatide was made to change

Drug researchers made tirzepatide to curb hunger and help with blood sugar. It’s a 39-amino-acid drug, meaning a chain of protein pieces. A fatty part helps tirzepatide stay in your body longer [1].

That’s how the design keeps the drug in your body for several days. All nine large phase-3 studies done before approval used one shot each week [18]. A study schedule doesn’t set your own treatment.

Two gut hormones matter here. GLP-1 helps you feel full, while GIP helps your body send insulin into the blood after food; in dish tests, tirzepatide’s GLP-1 effect was about five times weaker than your own GLP-1, yet lasted longer [1]. A dish test can’t tell how much your weight or blood sugar will change.

Researchers tested the GLP-1 and GIP drug in diabetes studies called SURPASS and weight studies called SURMOUNT [4][5]. Those names don’t mean more than groups of studies. I’d ask which result fits the reason for your clinic visit.

What researchers learned after making tirzepatide

Researchers tested a 39-amino-acid drug, meaning a chain of protein pieces, that copies GLP-1 and GIP. Adults with type 2 diabetes joined 5 studies. Adults with obesity joined 4. Other work covered sleep apnea and people with type 2 diabetes at high heart risk.

For type 2 diabetes, tirzepatide received FDA approval during May 2022. The FDA added long-term weight care in November 2023. Sleep apnea approval came in December 2024 [16]. Those dates can’t tell whether tirzepatide fits your health.

What tirzepatide changed about body weight

SURMOUNT-1, a weight study, followed 2,539 adults with obesity for 72 weeks. None had type 2 diabetes. Average body-weight loss was 16.0% with 5 mg, 21.4% with 10 mg, and 22.5% with 15 mg. People on placebo, which had no tirzepatide, lost 2.4% [6].

GLP-1 may curb hunger and delay food as it leaves your stomach. Tirzepatide may also help the body respond to insulin. Lab dish cells released stored fat when GIP was active [21]. These possible reasons don’t tell what you’ll lose.

A 2024 study tested human and mouse fat cells, not whole people [21]. The cell work may help explain weight change, but it measured nobody’s weight. At the time, 22.5% with 15 mg was the largest average in this kind of approved-drug study.

Ozempic contains semaglutide, a medicine that works through GLP-1 alone. That difference may help explain the direct tirzepatide vs semaglutide results. The page also covers the SURMOUNT weight findings and the SURMOUNT-5 study. Ask how many people left early and how long your clinic would follow you.

What GLP-1 alone doesn’t explain about tirzepatide

Tirzepatide copies GLP-1, which helps with hunger and blood sugar. It also copies GIP, the gut hormone that helps send insulin into the blood after food. Semaglutide works through GLP-1 but not GIP. It’s the results in people that matter more than GLP-1 and GIP labels.

In dish tests, tirzepatide kept one GLP-1 effect going inside cells for longer [1]. Through GIP, it worked about as strongly as the body’s own hormone. That may help explain the drug, but it can’t predict your result.

SURPASS-2 found a larger blood sugar change than semaglutide 1 mg [3]. In SURMOUNT-5, people lost more weight on tirzepatide than semaglutide 2.4 mg [10]. GIP may have helped, but neither study proved why the results differed. Ask which result bears on your health.

What studies didn’t prove about compounded tirzepatide

A licensed pharmacy can make compounded tirzepatide for one patient. The main drug is the kind studied in SURPASS and SURMOUNT. The mixed product isn’t FDA-approved for any use. Large phase-3 studies done before approval didn’t test the pharmacy-made versions.

The storage facts for dry research powder don’t apply to your supply. Lab workers add sterile water to that powder. Heat, light, air, and clumps may still damage the drug [18]. Ask your pharmacy which label and date belong to what you received.